{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:57:23Z","timestamp":1778914643644,"version":"3.51.4"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>Radiotherapy (RT) is an effective treatment for localized gastric mucosa-associated lymphoid tissue (MALT) lymphomas unresponsive to antibiotic therapy; however, irradiating the stomach can result in significant radiation to the heart, a risk factor for cardiac disease. We analyzed the Surveillance, Epidemiology, and End Results database to evaluate outcomes related to cardiac disease among patients treated with RT for stage I gastric MALT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods:<\/jats:title>\n            <jats:p>We identified adult patients treated between 1993 and 2014. The relationship between treatment modality (RT, chemotherapy, combination, and no treatment) and overall survival (OS), mucosa-associated lymphoid tissue-specific survival (MSS), non-mucosa-associated lymphoid tissue-specific survival (non-MSS), and cardiac-specific survival (CSS) was assessed using the Kaplan-Meier estimator and Cox proportional hazards analyses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 2996 patients (median follow-up, 5.6\u2009y) were analyzed: 27.5% had received RT alone, 12.1% chemotherapy alone, 3.9% chemoradiotherapy, and 56.5% no\/unknown treatment (including antibiotic therapy). Compared with RT alone, patients who received chemotherapy alone exhibited worse OS (hazard ratio [HR]: 1.67; 95% confidence interval [CI]: 1.32-2.10; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001) and MSS (HR: 2.10; 95% CI: 1.36-3.23; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.001). Although CSS appeared worse in patients who received chemotherapy (HR: 1.56; 95% CI: 0.92-2.66; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.10), it was not statistically significant. When comparing orbital and gastric MALT patients, there was no significant difference in CSS (HR: 0.80; 95% CI: 0.49-1.31; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.38).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>RT improved survival among patients with stage I gastric MALT without increasing the risk of cardiac death. Those with gastric MALT exhibited similar CSS to those with orbital MALT. Although we cannot analyze nonfatal cardiac toxicity, these results suggest that, absent antibiotic therapy, RT should remain first-line treatment for early-stage gastric MALT.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/coc.0000000000000747","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T11:13:18Z","timestamp":1598353998000},"page":"770-775","source":"Crossref","is-referenced-by-count":6,"title":["Radiotherapy in Early-stage Gastric MALT"],"prefix":"10.1097","volume":"43","author":[{"given":"Alexandra N.","family":"De Leo","sequence":"first","affiliation":[{"name":"Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Bates","sequence":"additional","affiliation":[{"name":"Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie A.","family":"Lockney","sequence":"additional","affiliation":[{"name":"Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy P.","family":"Mendenhall","sequence":"additional","affiliation":[{"name":"Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwan E.","family":"Shaikh","sequence":"additional","affiliation":[{"name":"Medicine, University of Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher G.","family":"Morris","sequence":"additional","affiliation":[{"name":"Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradford S.","family":"Hoppe","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,8,24]]},"reference":[{"key":"R1-20230903","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.beha.2016.07.002","article-title":"Epidemiology and environmental aspects of marginal zone lymphomas","volume":"30","author":"Sriskandarajah","year":"2017","journal-title":"Best Pract Res Clin Haematol"},{"key":"R2-20230903","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0140-6736(93)91409-F","article-title":"Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori","volume":"342","author":"Wotherspoon","year":"1993","journal-title":"Lancet"},{"key":"R3-20230903","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cgh.2009.07.017","article-title":"Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma","volume":"8","author":"Zullo","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R4-20230903","doi-asserted-by":"crossref","first-page":"e12474","DOI":"10.1111\/hel.12474","article-title":"Anti-Helicobacter pylori therapy in localized gastric mucosa-associated lymphoid tissue lymphoma: a prospective, nationwide, multicenter study in Japan","volume":"23","author":"Sugizaki","year":"2018","journal-title":"Helicobacter"},{"issue":"suppl 6","key":"R5-20230903","doi-asserted-by":"crossref","first-page":"vi144","DOI":"10.1093\/annonc\/mdt343","article-title":"Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Zucca","year":"2013","journal-title":"Ann Oncol"},{"key":"R6-20230903","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.3748\/wjg.v16.i17.2158","article-title":"Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma","volume":"16","author":"Park","year":"2010","journal-title":"World J Gastroenterol"},{"key":"R7-20230903","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1002\/cncr.22326","article-title":"Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment","volume":"107","author":"Nakamura","year":"2006","journal-title":"Cancer"},{"key":"R8-20230903","doi-asserted-by":"crossref","first-page":"8014","DOI":"10.3748\/wjg.v21.i26.8014","article-title":"Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: a review","volume":"21","author":"Asano","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R10-20230903","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1200\/JCO.2005.04.031","article-title":"Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02\/96)","volume":"23","author":"Koch","year":"2005","journal-title":"J Clin Oncol"},{"key":"R11-20230903","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1200\/JCO.1998.16.5.1916","article-title":"Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone","volume":"16","author":"Schechter","year":"1998","journal-title":"J Clin Oncol"},{"key":"R12-20230903","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1200\/JCO.2003.06.085","article-title":"Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome","volume":"21","author":"Tsang","year":"2003","journal-title":"J Clin Oncol"},{"key":"R13-20230903","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/annonc\/mds623","article-title":"Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, International Extranodal Lymphoma Study Group study","volume":"24","author":"Wirth","year":"2013","journal-title":"Ann Oncol"},{"key":"R14-20230903","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/cncr.25226","article-title":"Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy","volume":"116","author":"Goda","year":"2010","journal-title":"Cancer"},{"key":"R15-20230903","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1634\/theoncologist.2015-0109","article-title":"Chemoimmunotherapy for mucosa-associated lymphoid tissue-type lymphoma: a review of the literature","volume":"20","author":"Kiesewetter","year":"2015","journal-title":"Oncologist"},{"key":"R16-20230903","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood-2002-11-3496","article-title":"Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type","volume":"102","author":"Conconi","year":"2003","journal-title":"Blood"},{"key":"R17-20230903","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1200\/JCO.2005.08.128","article-title":"Clinical activity of rituximab in gastric marginal zone non-Hodgkin\u2019s lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy","volume":"23","author":"Martinelli","year":"2005","journal-title":"J Clin Oncol"},{"key":"R18-20230903","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2141.2008.07486.x","article-title":"Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial","volume":"144","author":"Hancock","year":"2009","journal-title":"Br J Haematol"},{"key":"R19-20230903","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1200\/JCO.2011.40.6272","article-title":"Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study","volume":"31","author":"Zucca","year":"2013","journal-title":"J Clin Oncol"},{"key":"R20-20230903","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1385\/MO:22:1:057","article-title":"Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial","volume":"22","author":"Aviles","year":"2005","journal-title":"Med Oncol"},{"key":"R21-20230903","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/annonc\/mds644","article-title":"Comparative outcomes of oncologic therapy in gastric extranodal marginal zone (MALT) lymphoma: analysis of the SEER-Medicare database","volume":"24","author":"Olszewski","year":"2013","journal-title":"Ann Oncol"},{"key":"R22-20230903","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","article-title":"Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"92","author":"Yahalom","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R23-20230903","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1200\/JCO.18.01764","article-title":"Therapy-Related Cardiac Risk in Childhood Cancer Survivors: An Analysis of the Childhood Cancer Survivor Study","volume":"37","author":"Bates","year":"2019","journal-title":"J Clin Oncol"},{"key":"R24-20230903","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11936-018-0627-x","article-title":"Radiation-induced cardiovascular toxicity: mechanisms, prevention, and treatment","volume":"20","author":"Spetz","year":"2018","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"R25-20230903","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1200\/JCO.2006.08.6595","article-title":"Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer","volume":"25","author":"Correa","year":"2007","journal-title":"J Clin Oncol"},{"key":"R26-20230903","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/14779072.2018.1538785","article-title":"Radiation and the heart: systematic review of dosimetry and cardiac endpoints","volume":"16","author":"Niska","year":"2018","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R27-20230903","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.3109\/10428194.2014.975802","article-title":"Proton therapy to the subdiaphragmatic region in the management of patients with Hodgkin lymphoma","volume":"56","author":"Sachsman","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"R28-20230903","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ijrobp.2019.02.002","article-title":"Outcomes after reduced-dose intensity modulated radiation therapy for gastric mucosa-associated lymphoid tissue (MALT) lymphoma","volume":"104","author":"Pinnix","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R29-20230903","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"R30-20230903","first-page":"1023","article-title":"Validity of the Ann Arbor staging classification for the non-Hodgkin\u2019s lymphomas","volume":"61","author":"Rosenberg","year":"1977","journal-title":"Cancer Treat Rep"},{"key":"R31-20230903","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"R32-20230903","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/gutjnl-2011-300495","article-title":"Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan","volume":"61","author":"Nakamura","year":"2012","journal-title":"Gut"},{"key":"R33-20230903","doi-asserted-by":"crossref","first-page":"8181","DOI":"10.3748\/wjg.v19.i45.8181","article-title":"Helicobacter pylori and gastric mucosa-associated lymphoid tissue lymphoma: recent progress in pathogenesis and management","volume":"19","author":"Nakamura","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R34-20230903","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11894-016-0509-x","article-title":"Eradication of Helicobacter pylori Infection","volume":"18","author":"Marcus","year":"2016","journal-title":"Curr Gastroenterol Rep"},{"key":"R35-20230903","doi-asserted-by":"crossref","first-page":"1372.e1","DOI":"10.1053\/j.gastro.2018.07.007","article-title":"Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization Regions","volume":"155","author":"Savoldi","year":"2018","journal-title":"Gastroenterology"},{"key":"R36-20230903","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3349\/ymj.2002.43.5.601","article-title":"Low grade MALT lymphoma of the stomach: treatment outcome with radiotherapy alone","volume":"43","author":"Park","year":"2002","journal-title":"Yonsei Med J"},{"key":"R37-20230903","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.radonc.2008.12.004","article-title":"Favorable outcomes of radiotherapy for early-stage mucosa-associated lymphoid tissue lymphoma","volume":"90","author":"Tomita","year":"2009","journal-title":"Radiother Oncol"},{"key":"R38-20230903","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.radonc.2008.03.012","article-title":"Radiotherapy for 41 patients with stages I and II MALT lymphoma: a retrospective study","volume":"87","author":"Yamashita","year":"2008","journal-title":"Radiother Oncol"},{"key":"R39-20230903","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.radonc.2008.02.012","article-title":"Long-term results of stomach-conserving therapy in gastric MALT lymphoma","volume":"87","author":"Vrieling","year":"2008","journal-title":"Radiother Oncol"},{"key":"R40-20230903","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12032-009-9207-y","article-title":"Treatment of low-grade gastric MALT-lymphoma unresponsive to Helicobacter pylori therapy: a pooled-data analysis","volume":"27","author":"Zullo","year":"2010","journal-title":"Med Oncol"},{"key":"R41-20230903","first-page":"57","article-title":"Gastric and non-gastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a single-center experience","volume":"24","author":"Vural","year":"2007","journal-title":"Turk J Haematol"},{"key":"R42-20230903","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1055\/s-0029-1246012","article-title":"Outcome and quality of life favour a conservative treatment of patients with primary gastric lymphoma","volume":"49","author":"Fischbach","year":"2011","journal-title":"Z Gastroenterol"},{"key":"R43-20230903","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/j.prro.2015.11.016","article-title":"Underutilization of radiation therapy in early-stage marginal zone lymphoma negatively impacts overall survival","volume":"6","author":"Ling","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"R44-20230903","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"R45-20230903","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3857\/roj.2016.01865","article-title":"Radiation therapy for gastric mucosa-associated lymphoid tissue lymphoma: dose-volumetric analysis and its clinical implications","volume":"34","author":"Lim","year":"2016","journal-title":"Radiat Oncol J"},{"key":"R46-20230903","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00535-018-1517-4","article-title":"Sequential H. pylori eradication and radiation therapy with reduced dose compared to standard dose for gastric MALT lymphoma stages IE & II1E: a prospective randomized trial","volume":"54","author":"Schmelz","year":"2019","journal-title":"J Gastroenterol"},{"key":"R47-20230903","doi-asserted-by":"crossref","first-page":"e00438","DOI":"10.1128\/AAC.00438-18","article-title":"Systematic review, meta-analysis, and network meta-analysis of the cardiovascular safety of macrolides","volume":"62","author":"Gorelik","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"R49-20230903","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/MLR.0000000000000073","article-title":"Comparison of SEER treatment data with Medicare claims","volume":"54","author":"Noone","year":"2016","journal-title":"Med Care"},{"key":"R50-20230903","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ijrobp.2004.10.025","article-title":"Radiation treatment planning techniques for lymphoma of the stomach","volume":"62","author":"Della Biancia","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000000747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T04:09:46Z","timestamp":1693714186000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000000747"}},"subtitle":["Improved Survival Without Increased Cardiac Death"],"short-title":[],"issued":{"date-parts":[[2020,8,24]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000000747","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,24]]}}}